机构：[1]Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China;[2]Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China;[3]Sun Yat Sen Univ, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China;[4]First Peoples Hosp Guangzhou, Guangzhou, Guangdong, Peoples R China;[5]PLA Guangzhou Mil Area, Gen Hosp, Guangzhou, Guangdong, Peoples R China;[6]Tradit Chinese Med Hosp Guangdong Prov, Guangzhou, Guangdong, Peoples R China;广东省中医院[7]Shenzhen Second Peoples Hosp, Shenzhen, Peoples R China;[8]Lianjiang City Pepoles Hosp, Lianjiang, Peoples R China;[9]Guangxi Med Univ, Affiliated Hosp 1, Guilin, Guangxi, Peoples R China
第一作者机构：[1]Sun Yat Sen Univ, Ctr Canc, Dept Breast Oncol, Guangzhou 510275, Guangdong, Peoples R China;
推荐引用方式(GB/T 7714)：
Wang X.,Yuan Z.,Liu D.,et al.SAFETY OF METRONOMIC CAPECITABINE THERAPY FOR EARLY TRIPLE NEGATIVE BREAST CANCER (SYSUCC-001 TRIAL)[J].BREAST.2013,22:S85-S85.
APA：
Wang, X.,Yuan, Z.,Liu, D.,Wang, S.,Zhao, L....&Zeng, J..(2013).SAFETY OF METRONOMIC CAPECITABINE THERAPY FOR EARLY TRIPLE NEGATIVE BREAST CANCER (SYSUCC-001 TRIAL).BREAST,22,
MLA：
Wang, X.,et al."SAFETY OF METRONOMIC CAPECITABINE THERAPY FOR EARLY TRIPLE NEGATIVE BREAST CANCER (SYSUCC-001 TRIAL)".BREAST 22.(2013):S85-S85
